Health Technology Assessment in Japan: Policy, Pharmacoeconomic Methods and Guidelines, Value, and Beyond
Autor Isao Kamaeen Limba Engleză Hardback – 20 sep 2019
This guidebook is authored by Japan’s foremost expert in HTA and pharmacoeconomics, with a view to strengthening the reader’s expertise in value-based healthcare and decision-making. The methods presented are essential to informing regulatory, local and patient decisions; as such, the book is equally recommended to industry and government, as well as academia, and anyone with an interest in Japanese HTA.
Preț: 456.10 lei
Preț vechi: 536.59 lei
-15% Nou
Puncte Express: 684
Preț estimativ în valută:
87.29€ • 92.09$ • 72.74£
87.29€ • 92.09$ • 72.74£
Carte disponibilă
Livrare economică 12-26 decembrie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789811357923
ISBN-10: 9811357927
Pagini: 186
Ilustrații: XVI, 265 p. 118 illus., 94 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.5 kg
Ediția:1st ed. 2019
Editura: Springer Nature Singapore
Colecția Adis
Locul publicării:Singapore, Singapore
ISBN-10: 9811357927
Pagini: 186
Ilustrații: XVI, 265 p. 118 illus., 94 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.5 kg
Ediția:1st ed. 2019
Editura: Springer Nature Singapore
Colecția Adis
Locul publicării:Singapore, Singapore
Cuprins
1. Basics to Know.- 2. New HTA Policy in Japan.- 3. MHLW Guideline for Cost-effectiveness Analysis.- 4. How to Appraise.- 5. Exercises for Powerful Assessment.- 6. Intermediate Level Methods.- 7.Advanced Research Topics.
Notă biografică
Isao Kamae is a professor of HTA project, Graduate School of Public Policy, The University of Tokyo, Japan. He also serves as a research director, The Canon Institute for Global Studies, Tokyo and an advisory expert for WHO and OECD. He has previously worked as an associate professor at Shimane Medical University in 1993-94 and Kyoto University Hospital in 1994-97, a professor, Kobe University School of Medicine in 1997-2007 and Keio University in 2007-2012.
His research interest is primarily in pharmacoeconomics and health technology assessment.
He has published 180 papers and completed work on 31 books. He serves as an editorial board member for Value in Health Regional Issues and Journal of Medical Economics. He has also been awarded ISPOR Distinguished Service Award four times regarding the first Asia-origin ISPOR Board of Director 2004-2006, etc.
He has published 180 papers and completed work on 31 books. He serves as an editorial board member for Value in Health Regional Issues and Journal of Medical Economics. He has also been awarded ISPOR Distinguished Service Award four times regarding the first Asia-origin ISPOR Board of Director 2004-2006, etc.
Textul de pe ultima copertă
Representing the first book on the topic, this work offers the reader an introduction to the Japanese systems for health technology assessment (HTA) officially introduced by the Ministry of Health, Labour and Welfare (MHLW) in 2016. Policy and guidelines are discussed, with the relevant methods and conditions of cost-effectiveness analysis explained alongside. Numerous instructive examples and exercises, ranging from basic to advanced, impart valuable knowledge and insight on the quantitative methods for economic evaluation, which will appeal to both beginners and experts.
This guidebook is authored by Japan’s foremost expert in HTA and pharmacoeconomics, with a view to strengthening the reader’s expertise in value-based healthcare and decision-making. The methods presented are essential to informing regulatory, local and patient decisions; as such, the book is equally recommended to industry and government, as well as academia, and anyone with an interest in Japanese HTA.
This guidebook is authored by Japan’s foremost expert in HTA and pharmacoeconomics, with a view to strengthening the reader’s expertise in value-based healthcare and decision-making. The methods presented are essential to informing regulatory, local and patient decisions; as such, the book is equally recommended to industry and government, as well as academia, and anyone with an interest in Japanese HTA.